FDA approves new Actos bladder cancer warning


The Food and Drug Administration has approved a new warning about the link between the diabetes drug Actos and bladder cancer. The agency called for the new warning after a study found that patients who use Actos for at least one year are 40% more likely to develop bladder cancer.

LOADING PDF: If there are any problems, click here to download the file.